Cronos Group Inc. Stock price

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-03-18 pm EDT 5-day change 1st Jan Change
3.04 CAD +6.67% Intraday chart for Cronos Group Inc. +14.72% +9.75%
Sales 2024 * 136M 100M Sales 2025 * 163M 120M Capitalization 1.16B 855M
Net income 2024 * -22M -16.22M Net income 2025 * -8M -5.9M EV / Sales 2024 * -0.2 x
Net cash position 2024 * 1.19B 875M Net cash position 2025 * 1.19B 878M EV / Sales 2025 * -0.2 x
P/E ratio 2024 *
-48.9 x
P/E ratio 2025 *
-130 x
Employees 356
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.49%
More Fundamentals * Assessed data
Dynamic Chart
Cronos Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Toronto Stocks Advance; Canadian Imperial Bank of Commerce Up on 1Q Profit, Revenue Rise DJ
Cronos Group Reports Consolidated Net Revenue Rose 9% in Q4 2023 MT
Transcript : Cronos Group Inc., Q4 2023 Earnings Call, Feb 29, 2024
Cronos Group Brief: Says Ended 2023 with approximately US$862 million in cash and short-term investments MT
Cronos Group Brief: Net revenue in Canada increased 20% in Q4 2023 Vs Q4 2022; On a constant currency basis net revenue in Canada increased 21% in Q4 2023 Vs Q4 2022 MT
Cronos Group Brief: On a constant currency basis consolidated net revenue increased 11% in Q4 2023 compared to Q4 2022 MT
Cronos Group Brief: Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022 MT
Cronos Group Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Fed's Preferred -2- DJ
Cronos Group Entering Australian Cannabis Market MT
Cronos Group Brief: Entering Australian Cannabis Market MT
Cronos Group Inc. Announces Launch of Its Highly Anticipated Lord Jones Live Resin Vapes in Two Different Hardware Options CI
Cronos Group Edges Down Premarket as it Raises C$23 Million in a Sale and Leaseback of an Ontario Property MT
Cronos Group Brief: Entering into agreement for the sale-leaseback of its Stayner, Ontario facility MT
More news
1 day+6.67%
1 week+14.72%
Current month+7.04%
1 month-0.33%
3 months+21.12%
6 months-0.33%
Current year+9.75%
More quotes
1 week
2.65
Extreme 2.65
3.04
1 month
2.56
Extreme 2.56
3.14
Current year
2.56
Extreme 2.56
3.14
1 year
2.15
Extreme 2.145
3.57
3 years
2.15
Extreme 2.145
12.75
5 years
2.15
Extreme 2.145
29.20
10 years
0.14
Extreme 0.14
32.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 37 15-11-05
Director of Finance/CFO 41 22-11-13
Chief Tech/Sci/R&D Officer 41 -
Members of the board TitleAgeSince
Director/Board Member 48 21-06-24
Director/Board Member 57 18-01-31
Director/Board Member 52 16-07-11
More insiders
Date Price Change Volume
24-03-18 3.04 +6.67% 303,505
24-03-15 2.85 +5.56% 149,363
24-03-14 2.7 -0.74% 116,601
24-03-13 2.72 +2.64% 121,934
24-03-12 2.65 0.00% 90,423

Delayed Quote Toronto S.E., March 18, 2024 at 04:00 pm EDT

More quotes
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, Happy Dance and PEACE+. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd., Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd., and Cronos Israel G.S. Pharmacy Ltd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3.04 CAD
Average target price
3.39 CAD
Spread / Average Target
+11.51%
Consensus
  1. Stock
  2. Equities
  3. Stock Cronos Group Inc. - Toronto S.E.